Three panelists representing the real estate, banking, and health care industries weighed in on innovation in Houston. Photo via Greater Houston Partnership/Facebook

Something has shifted in Houston, and businesses across industries — whether it be real estate, health care, or energy — are focused on innovation, emerging technologies, and the role of startups within the business community.

At the Greater Houston Partnership's annual Economic Outlook on December 5, three panelists from various industries gathered to discuss some of the biggest issues in Houston — from the multifamily real estate market to what the local workforce needs. The panel was moderated by Eddie Robinson, the morning news anchor for Houston Public Radio, and the panelists did weigh in a few issues affecting innovation.

Missed the talk? Here are a few overheard moments from the discussion.

"Houston allows you to do what you do. And you don't get that in other places."

Photo via Greater Houston Partnership/Facebook

Bradley R. Freels, chairman of Midway Cos. Freels says, while the city's been overshadowed by other Texas cities for innovation and tech — and even by its large oil and gas industry presence, the city is becoming a great place for startups. "This is a great place to do business because it's easy to get started in business here. I think it's just over shadowed to some degree," he says, adding later that, "the initiative around the innovation corridor is real."

"Houston is unique, in my opinion, in how open and welcoming it is."

Photo via Greater Houston Partnership/Facebook

— David Milich, CEO of UnitedHealthcare - Texas & Oklahoma. Building off the panelists point that Houston is a spirited, can-do city, Milich specifies that it's the collaboration between people in Houston that sets the city apart. "When we present ourselves with something to get done, we generally get it down."

"We're realizing that the economy is shifting. As we move forward in the 21st century, our entire workforce needs to be tech fluent."

Photo via Greater Houston Partnership/Facebook

Nataly Marks, managing director and region manager at JPMorgan Chase. When asked about jobs needed in Houston, Marks specified technology positions. Moreover, JPMorgan Chase is emphasizing getting the entire staff proficient in the latest tech resources.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.